MBD3 inhibits formation of liver cancer stem cells

Liver cancer cells can be reprogrammed into induced cancer stem cells (iCSCs) by exogenous expression of the reprogramming transcription factors Oct4, Sox2, Klf4 and c-Myc (OSKM). The nucleosome remodeling and deacetylase (NuRD) complex is essential for reprogramming somatic cells. In this study, we investigated the function of NuRD in the induction of liver CSCs. We showed that suppression of methyl-CpG binding domain protein 3 (MBD3), a core subunit of the NuRD repressor complex, together with OSKM transduction, induces conversion of liver cancer cells into stem-like cells. Expression of the transcription factor c-JUN is increased in MBD3-depleted iCSCs, and c-JUN activates endogenous pluripotent genes and regulates iCSC-related genes. These results indicate that MBD3/NuRD inhibits the induction of iCSCs, while c-JUN facilitates the generation of CSC-like properties. The iCSC reprogramming approach devised here provides a novel platform for dissection of the disordered signaling in liver CSCs. In addition, our results indicate that c-JUN may serve as a potential target for liver cancer therapy.

[1]  Yi-Wen Chang,et al.  Direct reprogramming of stem cell properties in colon cancer cells by CD44 , 2011, The EMBO journal.

[2]  D. Reinberg,et al.  The Dermatomyositis-Specific Autoantigen Mi2 Is a Component of a Complex Containing Histone Deacetylase and Nucleosome Remodeling Activities , 1998, Cell.

[3]  Y. Suh,et al.  c-Jun N-terminal kinase has a pivotal role in the maintenance of self-renewal and tumorigenicity in glioma stem-like cells , 2012, Oncogene.

[4]  Hiroaki Nakamura,et al.  Cancer stem-like cell marker CD44 promotes bone metastases by enhancing tumorigenicity, cell motility, and hyaluronan production. , 2013, Cancer research.

[5]  J. Nichols,et al.  The NuRD component Mbd3 is required for pluripotency of embryonic stem cells , 2006, Nature Cell Biology.

[6]  H. Clevers,et al.  KLF5 regulates the integrity and oncogenicity of intestinal stem cells. , 2014, Cancer research.

[7]  I. Grummt,et al.  NuRD Blocks Reprogramming of Mouse Somatic Cells into Pluripotent Stem Cells , 2013, Stem cells.

[8]  Zohar Mukamel,et al.  Deterministic direct reprogramming of somatic cells to pluripotency , 2013, Nature.

[9]  B. Spencer‐Dene,et al.  Embryonic NANOG Activity Defines Colorectal Cancer Stem Cells and Modulates through AP1‐ and TCF‐dependent Mechanisms , 2012, Stem cells.

[10]  A. Bird,et al.  Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. , 1999, Genes & development.

[11]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[12]  X. Wang,et al.  EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. , 2009, Gastroenterology.

[13]  Julian Gingold,et al.  Zfp281 mediates Nanog autorepression through recruitment of the NuRD complex and inhibits somatic cell reprogramming , 2012, Proceedings of the National Academy of Sciences.

[14]  Yong-Yeon Cho,et al.  JNK1 and 2 play a negative role in reprogramming to pluripotent stem cells by suppressing Klf4 activity. , 2014, Stem cell research.

[15]  C. Chai,et al.  Positive Feedback Loop of OCT4 and c‐JUN Expedites Cancer Stemness in Liver Cancer , 2016, Stem cells.

[16]  A. Behrens,et al.  c-Jun N-terminal phosphorylation antagonises recruitment of the Mbd3/NuRD repressor complex , 2011, Nature.

[17]  J. Huse,et al.  Osteopontin-CD44 signaling in the glioma perivascular niche enhances cancer stem cell phenotypes and promotes aggressive tumor growth. , 2014, Cell stem cell.

[18]  G. Pan,et al.  The oncogene c-Jun impedes somatic cell reprogramming , 2015, Nature Cell Biology.

[19]  S. Huang,et al.  Oct4 is a critical regulator of stemness in head and neck squamous carcinoma cells , 2014, Oncogene.

[20]  M. Todaro,et al.  Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity , 2008, Proceedings of the National Academy of Sciences.

[21]  Z. Yao,et al.  CD133+ cells with cancer stem cell characteristics associates with vasculogenic mimicry in triple-negative breast cancer , 2013, Oncogene.

[22]  A. Shilatifard,et al.  Zic2 is an enhancer-binding factor required for embryonic stem cell specification , 2015, Molecular cell.

[23]  A. Radzisheuskaya,et al.  MBD3/NuRD Facilitates Induction of Pluripotency in a Context-Dependent Manner , 2014, Cell stem cell.

[24]  M. Kanda,et al.  Epithelial to mesenchymal transition might be induced via CD44 isoform switching in colorectal cancer , 2014, Journal of surgical oncology.

[25]  R. Rintoul,et al.  CD133+ cancer stem-like cells in small cell lung cancer are highly tumorigenic and chemoresistant but sensitive to a novel neuropeptide antagonist. , 2014, Cancer research.

[26]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[27]  Jignesh R. Parikh,et al.  Alternative splicing of MBD2 supports self-renewal in human pluripotent stem cells. , 2014, Cell stem cell.

[28]  D. Lai,et al.  KLF5 strengthens drug resistance of ovarian cancer stem‐like cells by regulating survivin expression , 2013, Cell proliferation.

[29]  Stuart H. Orkin,et al.  A Myc Network Accounts for Similarities between Embryonic Stem and Cancer Cell Transcription Programs , 2010, Cell.